ClinicalTrials.Veeva

Menu

OCT-angiography as a Pronostic Marker for Visual Impairment in Patients Undergoing Neurosurgery for Compressive Macroadenoma : a Prospective Study. (FIRST)

C

Centre Hospitalier Universitaire de Nice

Status

Completed

Conditions

Pituitary Adenoma

Treatments

Procedure: Neurosurgery

Study type

Interventional

Funder types

Other

Identifiers

NCT04074642
19-AOI-06

Details and patient eligibility

About

The aim of the study is to assess accurancy of OCT angiography as a pronostic marker for patients undergoing neurosurgery for compressiver macroadenoma as compared with visual acuity, visual field and OCT.

Enrollment

21 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • pituitary compressive adenoma (for experimental group)
  • pituitary non compressive adenoma

Exclusion criteria

  • retinian disease
  • amblyopia
  • parkinson disease
  • pregnant woman

Trial design

Primary purpose

Prevention

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

21 participants in 2 patient groups

Non compressive adenoma
No Intervention group
Description:
Optical Coherence Tomography Angiography without surgery
Compressive adenoma
Experimental group
Description:
Optical Coherence Tomography Angiography before and after neurosurgery
Treatment:
Procedure: Neurosurgery

Trial contacts and locations

2

Loading...

Central trial contact

ARNAUD MARTEL

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems